Vaxxinity Stock (NASDAQ: VAXX) stock price, news, charts, stock research, profile.
Open | $0.422 |
Close | $0.465 |
Volume / Avg. | 435.874K / 432.557K |
Day Range | 0.420 - 0.500 |
52 Wk Range | 0.391 - 3.100 |
Market Cap | $59.850M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 9.54% |
Days to Cover | 16.47 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vaxxinity (NASDAQ: VAXX) through any online brokerage.
Other companies in Vaxxinity’s space includes: Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Eagle Pharmaceuticals (NASDAQ:EGRX) and Immuneering (NASDAQ:IMRX).
The latest price target for Vaxxinity (NASDAQ: VAXX) was reported by Baird on Friday, September 8, 2023. The analyst firm set a price target for 7.00 expecting VAXX to rise to within 12 months (a possible 1382.42% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Vaxxinity (NASDAQ: VAXX) is $0.4722 last updated April 18, 2024 at 7:54 PM EDT.
There are no upcoming dividends for Vaxxinity.
Vaxxinity’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Vaxxinity.
Vaxxinity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.